Skip to content

H.R. 1466 · 118th Congress (2023–2025)

Safe RESEARCH Act

This bill prohibits the National Institutes of Health (NIH) from conducting or supporting research on human fetal tissue obtained from an abortion procedure. It also imposes other restrictions on human fetal tissue research.

Under the bill, the NIH may conduct or support research on human fetal tissue only if it was obtained from a stillbirth. Current law allows research on tissue from stillbirths or from spontaneous or induced abortions.

The bill also applies informed consent and other requirements applicable to research on the transplantation of human fetal tissue for therapeutic purposes to all research with human fetal tissue. This includes research on stem cells and other human fetal tissue alternatives.

Additionally, human fetal tissue used for this research must be obtained in accordance with state anatomical gift laws. These laws govern organ and tissue donation for therapeutic, research, and other purposes. Some states already apply anatomical gift laws to human fetal tissue donation.

Currently, executive branch officials may not prohibit the NIH from conducting or supporting research on the transplantation of human fetal tissue for therapeutic purposes. The bill repeals this limitation on executive branch officials. It also repeals a requirement that the NIH fund certain proposals for this research.

Show official title

To amend the Public Health Service Act to prohibit research with human fetal tissue obtained pursuant to an abortion, and for other purposes.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to Health

This bill’s path

This is H.R. 1466’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Lisa C. McClain (R-MI-9)
Cosponsors
19 cosponsors

18 original · 1 later

19 R

  1. Rep. Rick W. Allen (R-GA-12)· Original · Mar 8, 2023
  2. Rep. Mike Bost (R-IL-12)· Original · Mar 8, 2023
  3. Rep. Andy Biggs (R-AZ-5)· Original · Mar 8, 2023
  4. Rep. Jeff Duncan (R-SC-3)· Original · Mar 8, 2023
  5. Rep. Randy Feenstra (R-IA-4)· Original · Mar 8, 2023
  6. Rep. Scott Franklin (R-FL-18)· Original · Mar 8, 2023
  7. Rep. Paul A. Gosar (R-AZ-9)· Original · Mar 8, 2023
  8. Rep. Glenn Grothman (R-WI-6)· Original · Mar 8, 2023
  9. Rep. Garret Graves (R-LA-6)· Original · Mar 8, 2023
  10. Rep. Bob Good (R-VA-5)· Original · Mar 8, 2023
  11. Rep. Andy Harris (R-MD-1)· Original · Mar 8, 2023
  12. Rep. Mike Johnson (R-LA-4)· Original · Mar 8, 2023
  13. Rep. John Joyce (R-PA-13)· Original · Mar 8, 2023
  14. Rep. Mary E. Miller (R-IL-15)· Original · Mar 8, 2023
  15. Rep. Barry Moore (R-AL-2)· Original · Mar 8, 2023
  16. Rep. Ralph Norman (R-SC-5)· Original · Mar 8, 2023
  17. Rep. Bill Posey (R-FL-8)· Original · Mar 8, 2023
  18. Rep. W. Gregory Steube (R-FL-17)· Original · Mar 8, 2023
  19. Rep. Michael R. Turner (R-OH-10)· Later · Jan 31, 2024
Policy area
Health
Subjects
  • Abortion
  • Administrative law and regulatory procedures
  • Cell biology and embryology
  • Department of Health and Human Services
  • Medical research
  • Organ and tissue donation and transplantation
  • Research administration and funding

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 2 committee actions · Mar 8, 2023 – Mar 17, 2023
    1. Referred to committee

      Referred to the House Committee on Energy and Commerce.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
  3. Expired

    Introduced → Referred to House Health → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Mar 8, 2023
  2. HouseHealthReferred Mar 17, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (3)
  1. Safe RESEARCH Act

    Display title, Short title · Introduced in House

  2. Safe Responsible Ethical Scientific Endeavors Assuring Research for Compassionate Healthcare Act

    Short title · Introduced in House

  3. To amend the Public Health Service Act to prohibit research with human fetal tissue obtained pursuant to an abortion, and for other purposes.

    Official title · Introduced in House